CI Cigna Group (CI) Q1 FY26 earnings call
Cordani's final call as CEO framed a clean July handoff to Evanko off a strong start: both Evernorth specialty and Cigna Healthcare beat, letting management lift the full-year EPS floor. The forward stance is disciplined portfolio-sharpening — exiting individual exchange and reviewing EviCore — while funding specialty, the Signature rebate-free pharmacy build and AI-driven affordability. The MCR beat carries an explicit prudence caveat as cost trend stays elevated.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
CI operating KPIs by quarter
| KPI | Mar 2025 Q1 FY25 | Sep 2025 Q3 FY25 | This call Mar 2026 Q1 FY26 | Jun 2026 Q2 FY26 | Change vs prior quarter |
|---|---|---|---|---|---|
| Medical care ratio Cigna Healthcare | 82.2%The medical care ratio for the first quarter was 82.2%.Source: earnings call transcript | 84.8%Our overall Cigna Healthcare segment-wide medical care ratio was 84.8% for the quarter, driven by an updated view of risk adjustment in our individual exchange business.Source: earnings call transcript | 79.8%The medical care ratio for the first quarter was 79.8%.Source: earnings call transcript | 84.5%The medical care ratio for the second quarter was 84.5%, slightly ahead of expectations.Source: earnings call transcript | +4.7 pt |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.